To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids

NCT00053560 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus

Interventions

DRUG: Prasterone (GL701)

Sponsor

Genelabs Technologies